Greenland Mines (NASDAQ: GRML) announced on September 2, 2026, the closing of its acquisition of the Sarfartoq Nd-Pr Rare Earths Project in southwest Greenland, a transaction valued at $20 million in cash and $15 million in securities. The deal, completed on September 1, positions the company to advance the project toward a pre-feasibility study, with planned production that could represent a substantial share of the non-Chinese rare earth market.
According to the company, the Sarfartoq project's planned annual NdPr oxide production would account for approximately 34% of all NdPr oxide refined outside China at 2025 consumption levels during each of the project's nine scheduled operating years. This statistic underscores the strategic importance of the project in diversifying the global supply chain for rare earth elements, which are critical for magnets used in electric vehicles, wind turbines, and other clean energy technologies.
An independent Initial Assessment, based solely on the ST1 deposit, estimates a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%, including Indicated and Inferred Mineral Resources. These figures highlight the potential economic viability of the project, though further studies are needed to confirm reserves and feasibility.
With the acquisition complete, Greenland Mines plans to undertake targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, environmental and social baseline studies, and drone-based magnetic surveys. These activities are designed to advance Sarfartoq toward a pre-feasibility study, a critical step in the development of a mining project.
In connection with the transaction, Neo Performance Materials has become a strategic shareholder in Greenland Mines and retains offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production. This offtake agreement ensures a market for the project's output and supports processing at Neo's Silmet rare earth separation facility in Estonia, further integrating the project into Western supply chains.
The acquisition is part of Greenland Mines' broader strategy to build a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities. The company also advances its North Atlantic Critical Metals Corridor vision, linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
The news is significant because it represents a concrete step toward reducing global dependence on Chinese rare earth processing. As countries and companies seek to secure supply chains for critical minerals, projects like Sarfartoq could play a pivotal role in meeting demand for NdPr oxide, a key input for permanent magnets.
For investors and industry observers, the development signals progress in the rare earth sector outside China, with potential implications for pricing, supply security, and technological advancement. However, as with any mining project, there are risks and uncertainties, including those detailed in Greenland Mines' filings with the Securities and Exchange Commission.
Greenland Mines is a Nasdaq-listed company with operations in mining and biotech. Its mining division focuses on the Skaergaard Project in southeast Greenland and now the Sarfartoq project, while its biotech division includes Klotho's KLTO-202 for ALS. The company is committed to advancing its projects while adhering to regulatory and environmental standards.
